ENTRY       D00673                      Drug
NAME        Ranitidine hydrochloride (JP18/USP);
            Zantac (TN)
PRODUCT
  GENERIC   RANITIDINE (Ajanta Pharma USA)
            RANITIDINE (Amneal Pharmaceuticals LLC)
            RANITIDINE (Amneal Pharmaceuticals LLC)
            RANITIDINE (Amneal Pharmaceuticals of New York LLC)
            RANITIDINE (Aphena Pharma Solutions - Tennessee)
            RANITIDINE (Bryant Ranch Prepack)
            RANITIDINE (Glenmark Pharmaceuticals)
            RANITIDINE (Lannett Company)
            RANITIDINE (Medsource Pharmaceuticals)
            RANITIDINE (Pharmaceutical Associates)
            RANITIDINE (RedPharm Drug)
            RANITIDINE HYDROCHLORIDE (Dr. Reddy's Laboratories Limited)
            RANITIDINE HYDROCHLORIDE (Sandoz)
            RANITIDINE HYDROCHLORIDE (Zydus Lifesciences Limited)
            RANITIDINE HYDROCHLORIDE (Zydus Lifesciences Limited)
            RANITIDINE HYDROCHLORIDE (Zydus Pharmaceuticals USA)
            RANITIDINE HYDROCHLORIDE (Zydus Pharmaceuticals USA)
FORMULA     C13H22N4O3S. HCl
EXACT_MASS  350.1179
MOL_WEIGHT  350.8647
CLASS       Gastrointestinal agent
             DG01975  Agents for peptic ulcer
              DG01481  Histamine receptor H2 antagonist
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
            Transporter substrate
             DG02854  SLC22A2 substrate
            Transporter inhibitor
             DG02863  SLC22A2 inhibitor
REMARK      ATC code: A02BA02
            Chemical structure group: DG00018
            Product (DG00018): D00673<US>
EFFICACY    Anti-ulcerative, H2 receptor antagonist
  DISEASE   Duodenal ulcer [DS:H01634]
            Zollinger-Ellison syndrome [DS:H01522]
            Gastric ulcer [DS:H01634]
            GERD [DS:H01602]
TARGET      HRH2 [HSA:3274] [KO:K04150]
  PATHWAY   hsa04020(3274)  Calcium signaling pathway
            hsa04080(3274)  Neuroactive ligand-receptor interaction
            hsa04971(3274)  Gastric acid secretion
METABOLISM  Transporter: SLC22A2 [HSA:6582]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565], CYP3A [HSA:1576 1577 1551]
            Transporter inhibition: SLC22A2 [HSA:6582]
STR_MAP     map07038  Antiulcer drugs
            map07227  Histamine H2/H3 receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A02 DRUGS FOR ACID RELATED DISORDERS
               A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
                A02BA H2-receptor antagonists
                 A02BA02 Ranitidine
                  D00673  Ranitidine hydrochloride (JP18/USP) &lt;US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Histamine2 (H2) Receptor Antagonists
               Ranitidine
                D00673  Ranitidine hydrochloride (JP18/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for digestive organs
              09 Histamine H2 receptor blocker containing drugs
               D00673  Ranitidine hydrochloride (JP18/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             First-class OTC drugs
              Inorganic and organic chemicals
               Ranitidine
                D00673  Ranitidine hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG01481  Histamine receptor H2 antagonist
                DG00018  Ranitidine
                 D00673  Ranitidine hydrochloride
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00018  Ranitidine
                D00673  Ranitidine hydrochloride
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00018  Ranitidine
                D00673  Ranitidine hydrochloride
             Transporter substrate
              DG02854  SLC22A2 substrate
               DG00018  Ranitidine
                D00673  Ranitidine hydrochloride
             Transporter inhibitor
              DG02863  SLC22A2 inhibitor
               DG00018  Ranitidine
                D00673  Ranitidine hydrochloride
            Drug classes [BR:br08332]
             Gastrointestinal agent
              DG01481  Histamine receptor H2 antagonist
               D00673  Ranitidine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH2
                 D00673  Ranitidine hydrochloride (JP18/USP) &lt;US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00673  Ranitidine hydrochloride
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00673
             Drug transporters
              D00673
            Rx-to-OTC switch list in Japan [br08314.html]
             D00673
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG01481  Histamine receptor H2 antagonist
                DG00018  Ranitidine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00018  Ranitidine
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00018  Ranitidine
             Transporter substrate
              DG02854  SLC22A2 substrate
               DG00018  Ranitidine
             Transporter inhibitor
              DG02863  SLC22A2 inhibitor
               DG00018  Ranitidine
DBLINKS     CAS: 66357-59-3
            PubChem: 7847739
            ChEBI: 8777
            LigandBox: D00673
            NIKKAJI: J245.455F
ATOM        22
            1   C8y C    19.1062  -21.6933
            2   O2x O    20.2292  -22.5356
            3   C8x C    19.5273  -20.3597
            4   C1b C    17.8427  -22.3952
            5   C8y C    21.3523  -21.6933
            6   C8x C    20.9311  -20.3597
            7   N1c N    16.6495  -21.6933
            8   C1b C    22.5455  -22.3952
            9   C1a C    15.4562  -22.3952
            10  C1a C    16.6495  -20.2895
            11  S2a S    23.7388  -21.6933
            12  C1b C    25.0022  -22.3952
            13  C1b C    26.1956  -21.6933
            14  N1b N    27.3890  -22.3952
            15  C2c C    28.5822  -21.6933
            16  C2b C    29.8457  -22.3952
            17  N1b N    28.5822  -20.2895
            18  N2b N    31.0389  -21.6933 #+
            19  C1a C    27.3890  -19.5875
            20  O3a O    31.0389  -20.2895 #-
            21  O3a O    32.2322  -22.3952
            22  X   Cl   30.1262  -25.5343
BOND        21
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     5   8 1
            8     7   9 1
            9     7  10 1
            10    8  11 1
            11   11  12 1
            12   12  13 1
            13   13  14 1
            14   14  15 1
            15   15  16 2
            16   15  17 1
            17   16  18 1
            18   17  19 1
            19   18  20 1
            20   18  21 2
            21    5   6 2
///
